A phase III randomized study comparing concomitant standard cisplatin (P) - etoposide (E) and chest irradiation to concomitant etoposide plus daily cisplatin and chest irradiation as induction therapy for limited (LD) small-cell lung cancer (SCLC)

Berghmans, T.; Houtte, Paul Van; Lafitte, J.J.; Efremidis, Anna; Florin, M; Paesmans, Marianne; Leclercq, Nathalie; Sculier, J.P.

doi:10.1200/jco.2008.26.15_suppl.7521

JCO

2008

DOI: 10.1200/jco.2008.26.15_suppl.7521

|View full text |Cite

A phase III randomized study comparing concomitant standard cisplatin (P) - etoposide (E) and chest irradiation to concomitant etoposide plus daily cisplatin and chest irradiation as induction therapy for limited (LD) small-cell lung cancer (SCLC)

T. Berghmans¹,

Paul Van Houtte²,

J.J. Lafitte³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2008

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A phase III randomized study comparing concomitant standard cisplatin (P) - etoposide (E) and chest irradiation to concomitant etoposide plus daily cisplatin and chest irradiation as induction therapy for limited (LD) small-cell lung cancer (SCLC)

Cited by 1 publication

References 0 publications

Comment optimiser la radiothérapie dans le traitement des carcinomes bronchiques à petites cellules ?

Comment optimiser la radiothérapie dans le traitement des carcinomes bronchiques à petites cellules ?

Contact Info

Product

Resources

About